Ironwood Pharmaceuticals IRWD Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's interest expense?
- Ironwood Pharmaceuticals (IRWD) reported interest expense of $9.14M in Q1 2026.
- How has Ironwood Pharmaceuticals's interest expense changed year-over-year?
- Ironwood Pharmaceuticals's interest expense increased by 13.3% year-over-year, from $8.07M to $9.14M.
- What is the long-term trend for Ironwood Pharmaceuticals's interest expense?
- Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's interest expense has grown at a 1.3% compound annual growth rate (CAGR), from $31.15M to $32.75M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.